Whitehawk Therapeutics Inc
General ticker "WHWK" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $99.1M (TTM average)
Whitehawk Therapeutics Inc follows the US Stock Market performance with the rate: 15.9%.
Estimated limits based on current volatility of 3.4%: low 2.45$, high 2.62$
Short-term WHWK quotes
Long-term WHWK plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $15.22MM | $24.35MM | $25.98MM |
| Operating Expenses | $77.90MM | $96.29MM | $93.44MM |
| Operating Income | $-62.68MM | $-71.93MM | $-67.46MM |
| Non-Operating Income | $2.17MM | $6.17MM | $3.77MM |
| Interest Expense | $0.23MM | $0.23MM | $0.15MM |
| R&D Expense | $32.66MM | $48.93MM | $51.03MM |
| Income(Loss) | $-60.51MM | $-65.77MM | $-63.69MM |
| Profit(Loss)* | $-60.51MM | $-65.77MM | $-63.69MM |
| Stockholders Equity | $158.38MM | $105.19MM | $52.48MM |
| Inventory | $1.86MM | $6.43MM | $5.31MM |
| Assets | $184.24MM | $132.42MM | $70.32MM |
| Operating Cash Flow | $-49.64MM | $-59.66MM | $-59.55MM |
| Capital expenditure | $0.44MM | $3.97MM | $1.65MM |
| Investing Cash Flow | $-132.89MM | $83.21MM | $25.20MM |
| Financing Cash Flow | $72.62MM | $0.33MM | $0.13MM |
| Earnings Per Share** | $-2.69 | $-2.44 | $-2.36 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.